Boston Scientific Derivatives increased by 9.0% to $97.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 42.3%, from $168.00M to $97.00M. Over 4 years (FY 2020 to FY 2024), Derivatives shows an upward trend with a 23.1% CAGR.
Higher values indicate favorable short-term hedging positions that may provide cash inflows within the next year.
This represents the fair value of derivative financial instruments that are expected to be settled or realized within th...
Commonly reported by utilities to manage short-term fuel procurement risks.
current_assets_derivative_assets_current| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $167.00M | $192.00M | $226.00M | $266.00M | $286.00M | $367.00M | $232.00M | $187.00M | $234.00M | $241.00M | $159.00M | $177.00M | $267.00M | $168.00M | $305.00M | $221.00M | $89.00M | $97.00M |
| QoQ Change | — | +15.0% | +17.7% | +17.7% | +7.5% | +28.3% | -36.8% | -19.4% | +25.1% | +3.0% | -34.0% | +11.3% | +50.8% | -37.1% | +81.5% | -27.5% | -59.7% | +9.0% |
| YoY Change | — | — | — | — | +71.3% | +91.1% | +2.7% | -29.7% | -18.2% | -34.3% | -31.5% | -5.3% | +14.1% | -30.3% | +91.8% | +24.9% | -66.7% | -42.3% |